CIK: 0001799883 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value ($000): $401,433 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ELVN | ENLIVEN THERAPEUTICS INC | 5,798,475 | $118,347 | 29.5% | $20.34 | -0.6% | COM | 29337E102 |
| TRDA | ENTRADA THERAPEUTICS INC | 4,408,379 | $66,743 | 16.6% | $17.12 | — | COM | 29384C108 |
| IRON | DISC MEDICINE INC | 488,442 | $21,687 | 5.4% | $49.79 | -28.7% | COM | 254604101 |
| — | RALLYBIO CORP | 3,630,724 | $20,550 | 5.1% | $17.58 | — | COM | 75120L100 |
| — | VOR BIOPHARMA INC | 6,361,723 | $19,658 | 4.9% | $43.10 | — | COM | 929033108 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 357,486 | $18,232 | 4.5% | $25.81 | +4.3% | CLASS A ORD | 61559X104 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 862,286 | $15,538 | 3.9% | $19.04 | +4.7% | COM | 22663K107 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 490,000 | $13,823 | 3.4% | $23.99 | 0.0% | COM | 98943L107 |
| — | SCPHARMACEUTICALS INC | 1,200,647 | $12,235 | 3.0% | $5.92 | — | COM | 810648105 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 310,270 | $10,527 | 2.6% | $33.70 | 0.0% | COM NEW | 15117B202 |
| VKTX | VIKING THERAPEUTICS INC | 585,000 | $9,483 | 2.4% | $14.60 | +43.5% | COM | 92686J106 |
| COGT | COGENT BIOSCIENCES INC | 790,440 | $9,359 | 2.3% | $6.91 | +66.0% | COM | 19240Q201 |
| PHVS | PHARVARIS N V | 587,600 | $8,896 | 2.2% | $18.63 | -48.3% | COM | N69605108 |
| ARVN | ARVINAS INC | 320,000 | $7,942 | 2.0% | $29.28 | -12.2% | COM | 04335A105 |
| RNAM | AVIDITY BIOSCIENCES INC | 665,555 | $7,381 | 1.8% | $18.92 | -33.7% | COM | 05370A108 |
| ANAB | ANAPTYSBIO INC | 357,733 | $7,276 | 1.8% | $28.24 | -28.2% | COM | 032724106 |
| — | MIRATI THERAPEUTICS INC | 192,500 | $6,955 | 1.7% | $36.13 | — | COM | 60468T105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 280,000 | $6,661 | 1.7% | $17.98 | +42.7% | COM | 92790C104 |
| — | SPRUCE BIOSCIENCES INC | 2,364,000 | $5,083 | 1.3% | $2.21 | — | COM | 85209E109 |
| — | MERSANA THERAPEUTICS INC | 1,305,000 | $4,293 | 1.1% | $4.03 | — | COM | 59045L106 |
| — | HOMOLOGY MEDICINES INC | 4,535,919 | $4,014 | 1.0% | $20.70 | — | COM | 438083107 |
| — | IMPEL PHARMACEUTICALS INC | 2,884,791 | $3,664 | 0.9% | $8.85 | — | COM | 45258K109 |
| GHRS | GH RESEARCH PLC | 152,022 | $1,804 | 0.4% | $10.26 | 0.0% | ORDINARY SHARES | G3855L106 |
| — | CIDARA THERAPEUTICS INC | 1,134,511 | $1,282 | 0.3% | $3.84 | — | COM | 171757107 |